A shockingly high number of pharmacy directors are unaware as to whether their outsourced compounding vendor has been inspected by their state board of pharmacy or the FDA. Conversely, those pharmacy directors who have reviewed their vendors’ responses to 483s and customer quality complaints have typically been satisfied with the corrective actions undertaken by their vendors. In addition, most pharmacy directors assign strong satisfaction ratings to their vendors, which underscores the growing trend in facilities planning to increase their outsourcing volume over the next 3 years.